Sep 27, 2018 - Aldeyra Therapeutics' (ALDX) dry eye candidate, reproxalap, achieves early onset of improvement in patients and a broad range of activity.
Sep 19, 2018 - AbbVie's (ABBV) shares fall on a lawsuit by California insurance department accusing it of giving illegal kickbacks to doctors for prescribing Humira.
Sep 18, 2018 - Alnylam had an eventful week.Karyopharm reports positive Phase 2 data.Teva’s migraine drug is approved.
Sep 14, 2018 - The FDA confers fast track designation on Ironwood's (IRWD) praliciguat for the treatment of heart failure with preserved ejection fraction.
Sep 14, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
Sep 10, 2018 - Revance is a clinical-stage biotechnology company focused on the development and commercialization of botulinum toxin (Botox) products for cosmetic and therapeutic applications.Near-term catalysts inc
Sep 10, 2018 - By 2025, the NASH treatment market will be worth between $20-35 billion (per various estimates).Intercept Pharmaceuticals and Genfit are leading the race to develop a drug for NASH fibrosis, and Aller
Sep 09, 2018 - Top Insider Buys Highlight for the Week of Sept. 7, Stocks: AXP,SLB,AGN,KDP, release date:Sep 07, 2018
Sep 05, 2018 - Allergan PLC (NYSE:AGN) 2018 Wells Fargo Healthcare Conference Call September 05, 2018 09:05 AM ET Executives Brent Saunders - Chief Executive Officer Analysts David Maris - Wells Fargo Securities Pre